Stock Exchange Announcements

REG-T&F Informa PLC Appointment of Non-Executive
RNS Number:3666C 
T&F Informa PLC 
27 August 2004 
 
27 August 2004 
 
                                T&F Informa plc 
 
                    Appointment of Non-Executive Director 
 
T&F Informa plc, a leading provider of high value, specialist information to the 
academic, professional and commercial markets, announced today the appointment 
of Pamela J. Kirby PhD as a Non-Executive Director of the company with effect 
from 1 September 2004. 
 
Dr Kirby (50) is currently a Non-Executive Director of Smith and Nephew plc and 
Oscient Pharmaceuticals Corporation. She was previously CEO of US based 
Quintiles Transnational Corporation, a  provider of product development and 
commercial services to the pharmaceutical and biotechnology industries. Prior to 
joining Quintiles, Dr Kirby held various senior positions in the pharmaceutical 
industry at Astra AB (now AstraZeneca PLC), British Biotech plc (now Vernalis 
plc) and F. Hoffmann-La Roche Limited. Dr Kirby has a PhD in Clinical 
Pharmacology from the University of London. 
 
Commenting on the appointment David Smith, Chairman of T&F Informa said: 
 
"Pam brings a great deal of business and corporate experience to the team, 
especially in the high growth life sciences and pharmaceutical markets where the 
enlarged group has significant positions and products. She also has strong 
experience in international markets." 
 
 
                                      ENDS 
 
For further information, please contact: 
 
T&F Informa plc                                         020 7017 5000 
David Smith, Chairman 
 
Financial Dynamics                                      020 7831 3113 
Tim Spratt / Charles Palmer 
 
 
 
 
                      This information is provided by RNS 
            The company news service from the London Stock Exchange 
END 
 
BOASESFAMSLSESA